Clinical Trial

Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls

Study acronym: SWECRIT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Blood samples are collected and stored in a biobank for later analysis of circulating substances in peripheral blood and genetic variations in patients with severe critical illness and risk of death. The aim is to analyze stored samples in order to identify substances that can help predict the outcome of critically ill patients, but also to optimize treatment and possibly prevent serious illness and death in the future.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-07-22; most recent amendment 2025-05-22.
Status change: Recruiting → Active, Not Recruiting 2022-02-09
Trial Details
NCT Number NCT04974775
Lead Sponsor Skane University Hospital
Collaborators: Region Skane, Lund University
Conditions Critical Illness, Cardiac Arrest, Sepsis, Influenza, Covid19, Trauma
Enrollment 8,500 participants
Start Date 2014-06
Primary Completion 2021-12 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-29